🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Hirotaka Komaba

ORCID: 0000-0002-1704-4507

Also affiliated with Tokai University, Japanese Society for Dialysis Therapy

MedicineNursingBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Serum total indoxyl sulfate and clinical outcomes in hemodialysis patients: results from the Japan Dialysis Outcomes and Practice Patterns Study”.

Serum total indoxyl sulfate and clinical outcomes in hemodialysis patients: results from the Japan Dialysis Outcomes and Practice Patterns Study

Clinical Kidney Journal(2020)10.1093/ckj/sfaa121

N/A

0DataRank · unranked

38 citations

Douglas S. Fuller, Hirotaka Komaba, Takanobu Nomura, Ziad A. Massy, Brian Bieber +4 more

Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine

American Journal of Kidney Diseases(2021)10.1053/j.ajkd.2021.05.006

N/A

0DataRank · unranked

52 citations

Takehiko Wada, Masafumi Fukagawa, Hirotaka Komaba

Chronic kidney disease–mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Kidney International(2025)10.1016/j.kint.2024.11.013

N/A

0DataRank · unranked

135 citations

Pieter Evenepoel, Rachel M. Holden, Tamara Isakova, Hanne Skou Jørgensen, Hirotaka Komaba +64 more